Search PubMed⌕ Search

Biomedical subjects

P Greenaway

Publications and source records attributed to P Greenaway.

16 recordsLinked to original sources
PubMed1992

High affinity, Ca2+ specific ATPase and Na+K(+)-ATPase in the gills of a supralittoral crab Leptograpsus variegatus.

1. The gills of Leptograpsus variegatus contain a high-affinity, Ca(2+)-activated ATPase, probably located in the basolateral plasma membrane of the gill epithelia. 2. The affinity of the ATPase for Ca2+ is in the micromolar concentration range (6-35 mumol/l). 3. The specific activity of the enzyme did not change during the moult cycle. The ATPase probably does not contribute substantially to increased calcium influx from the medium during the post moult period. 4. The enzyme is believed to function as a selective extrusion mechanism involved in the maintenance of a low cytosolic Ca2+ level in the epithelial cells.

Animals↗
PubMed1984

The detection of subtle differences between different orthopoxvirus genomes by heteroduplex analysis.

Corresponding DNA fragments from variola (Harvey) and monkeypox (Denmark) viruses which had been cloned into different plasmid vectors were subjected to heteroduplex analysis. Characteristic deletion loops corresponding to differences between the cloning vectors served as internal markers to identify and to orientate the heteroduplexed molecules. Partial denaturation of the resulting heteroduplexes was used as a primary screen to locate regions of heterogeneity between the poxvirus inserts. The denaturation threshold for homoduplexes was consistently higher than that for heteroduplexes. However, significant sequence divergence between corresponding fragments was indicated by larger than usual differences in thresholds between corresponding homo- and heteroduplexes. Denaturation bubbles of 0.1-0.5 kb were detected and hence small regions of heterogeneity between the genomes (180 kb) of variola and monkeypox viruses were localised. This procedure has a general application in comparative studies on large, complex but closely related DNA molecules.

Base Sequence↗
PubMed1976

The regulation of haemolymph calcium concentration of the crab Carcinus maenas (L.).

After acclimation, Carcinus can maintain calcium balance in dilute (35-100%) but not in low calcium sea water. 71% of total haemolymph calcium (9-54 +/- 0-42 mM) was in ionic form as compared with 90-9%(9-9mM) in sea water. On acclimation to dilute sea water the calcium activity of the haemolymph was greater than that of the medium, the difference being maintained by active calcium uptake. Carcinus is highly permeable to Ca2+, influx from sea water being 0-513 +/- 0-07 mumoles g-1 h-1 and the time constant for calcium influx 4-3 +/- 0-48 h. Calcium space represented ca. 25% wet body weight independent of body size or salinity of acclimation medium.

Animals↗
PubMedDate not supplied

Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccine.

Cynomolgus macaques were vaccinated with inactivated simian immunodeficiency virus-infected cells and 'Quil-A' as adjuvant at 0, 4, 8, and 36 weeks or at 0, 4, 8, and 16 weeks. 2 weeks later these animals, together with a similar unvaccinated group, were challenged with 10 MID50 (50% monkey infectious doses) of a pool of SIVmac251 previously titrated in vivo. Virus was repeatedly isolated from unvaccinated animals on at least five separate occasions and proviral DNA was detected in circulating lymphocytes by polymerase chain reaction amplification. By contrast, virus and proviral DNA were not found in any of the vaccinated animals. However, the same vaccination regimen used after live virus challenge did not eliminate virus from previously infected macaques.

Adjuvants, Immunologic↗
PubMedDate not supplied

A formalin inactivated whole SIVmac vaccine in Ribi adjuvant protects against homologous and heterologous SIV challenge.

Eight monkeys were immunized at 0, 4, 9, and 18 weeks with a total of 2 mg of formalin inactivated SIVmac vaccine with Ribi adjuvant. Two weeks after the last booster four immunized monkeys and two controls were challenged with 10 MID50 of live homologous virus SIVmac, and the remaining four vaccinated animals along with two controls were challenged with the heterologous SIVsm strain. All eight vaccinated monkeys resisted the virus challenge, whereas all controls became infected. Three months after the first challenge the monkeys were rechallenged with the same virus strain, without further boosting. Two of four vaccinated monkeys were still resistant to the homologous SIV strain, and three of four monkeys were resistant to the heterologous SIVsm strain. This study demonstrates vaccine induced cross-protection between SIV strains.

Adjuvants, Immunologic↗